Literature DB >> 26841362

Vascularized composite allotransplantation: a closer look at the banff working classification.

Michelle Schneider1, Adela Rambi G Cardones2, M Angelica Selim3, Linda C Cendales4.   

Abstract

The first Banff vascularized composite allotransplantation meeting was held in 2007 to standardize criteria for the characterization and reporting of severity and types of rejection. As a result, the 2007 Banff VCA working classification for skin allograft pathology was formalized and now serves as the standard for diagnosis of VCA rejection. Similar to other working classification systems, strengths and limitations have been identified including the adequacy of the specimen, the definition of severity between grades, the reproducibility, the adequacy of the specimens, the types of rejection, and the integration of newer technologies such as molecular and genomic approaches. Although a relatively few number of cases have been performed and followed up to date, additional phenotypes such as antibody-mediated rejection, fibrosis, atrophy, and vascular changes are being reported and characterized based on accumulated experience in the field of VCA and parallels with other solid organs. This study aims to consider strengths and limitations of the Banff VCA working system and highlights ongoing challenges and opportunities available related to histopathology in this emerging field of transplantation.
© 2016 Steunstichting ESOT.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26841362     DOI: 10.1111/tri.12750

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  11 in total

1.  The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.

Authors:  Christian Andreas Radu; Sebastian Fischer; Yannick Diehm; Otto Hetzel; Florian Neubrech; Laura Dittmar; Christian Kleist; Martha Maria Gebhard; Peter Terness; Ulrich Kneser; Jurij Kiefer
Journal:  Langenbecks Arch Surg       Date:  2017-08-19       Impact factor: 3.445

Review 2.  Accommodation and related conditions in vascularized composite allografts.

Authors:  Jeffrey L Platt; Christina L Kaufman; Mayara Garcia de Mattos Barbosa; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2017-10       Impact factor: 2.640

3.  Defining chronic rejection in vascularized composite allotransplantation-The American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation.

Authors:  Christina L Kaufman; Jean Kanitakis; Annemarie Weissenbacher; Gerald Brandacher; Mandeep R Mehra; Hatem Amer; Bettina G Zelger; Bernhard Zelger; Bohdan Pomahac; Sue McDiarmid; Linda Cendales; Emmanuel Morelon
Journal:  SAGE Open Med       Date:  2020-07-14

4.  The Evolving Clinical Presentation of Acute Rejection in Facial Transplantation.

Authors:  Valentin Haug; Branislav Kollar; Doha Obed; Harriet Kiwanuka; Marvee Turk; Luccie Wo; Sotirios Tasigiorgos; Maximillian Kueckelhaus; Leonardo V Riella; Bohdan Pomahac
Journal:  JAMA Facial Plast Surg       Date:  2019-07-01       Impact factor: 4.611

5.  Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection.

Authors:  Thet Su Win; William J Crisler; Beatrice Dyring-Andersen; Rachel Lopdrup; Jessica E Teague; Qian Zhan; Victor Barrera; Shannan Ho Sui; Sotirios Tasigiorgos; Naoka Murakami; Anil Chandraker; Stefan G Tullius; Bohdan Pomahac; Leonardo V Riella; Rachael A Clark
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

6.  Eponychial lesions following bilateral upper extremity vascular composite allotransplantation: a case report.

Authors:  Fedra Fallahian; David Molway; Saagar Jadeja; Rachael Clark; Francisco M Marty; Leonardo V Riella; Anil Chandraker; Simon G Talbot
Journal:  Case Reports Plast Surg Hand Surg       Date:  2018-02-02

7.  Noninvasive Monitoring of Allograft Rejection Using a Novel Epidermal Sampling Technique.

Authors:  Piul S Rabbani; William J Rifkin; Rohini L Kadle; Nakul Rao; J Rodrigo Diaz-Siso; Salma A Abdou; Eduardo D Rodriguez; Daniel J Ceradini
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-08-08

8.  Blood proteome profiling using aptamer-based technology for rejection biomarker discovery in transplantation.

Authors:  Andrey V Shubin; Branislav Kollar; Simon T Dillon; Bohdan Pomahac; Towia A Libermann; Leonardo V Riella
Journal:  Sci Data       Date:  2019-12-09       Impact factor: 6.444

9.  MMP3 Is a Non-invasive Biomarker of Rejection in Skin-Bearing Vascularized Composite Allotransplantation: A Multicenter Validation Study.

Authors:  Branislav Kollar; Audrey Uffing; Thiago J Borges; Andrey V Shubin; Bruno T Aoyama; Céline Dagot; Valentin Haug; Martin Kauke; Ali-Farid Safi; Simon G Talbot; Emmanuel Morelon; Stéphanie Dakpe; Bohdan Pomahac; Leonardo V Riella
Journal:  Front Immunol       Date:  2019-11-29       Impact factor: 7.561

10.  Increased levels of circulating MMP3 correlate with severe rejection in face transplantation.

Authors:  Branislav Kollar; Andrey Shubin; Thiago J Borges; Sotirios Tasigiorgos; Thet Su Win; Christine G Lian; Simon T Dillon; Xuesong Gu; Iris Wyrobnik; George F Murphy; Bohdan Pomahac; Towia A Libermann; Leonardo V Riella
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.